We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

IBM Opens Watson Health European Center of Excellence

By HospiMedica International staff writers
Posted on 21 Apr 2016
Image: IBM CEO Ginni Rometty and Italian Prime Minister Matteo Renzi witness the signing of the agreement for the planned Watson Health European Center of Excellence (Photo courtesy of IBM).
Image: IBM CEO Ginni Rometty and Italian Prime Minister Matteo Renzi witness the signing of the agreement for the planned Watson Health European Center of Excellence (Photo courtesy of IBM).
The IBM (Armonk, NY, USA) Watson Health analytics unit has announced it will open its first European Center of Excellence in Milan (Italy).

The Watson Health European Center of Excellence, part of a long-term collaboration between IBM and the government of Italy, will be located near the Human Technopole Italy 2040 research campus, supporting Italy's initiative to establish an international hub for the advancement of genomics, big data, aging, and nutrition. The formation of the Watson Health European Center of Excellence is also intended to encourage the development of a Pan-European ecosystem for healthcare reform, research, and health-tech start-ups.

IBM plans to invest up to USD 150 million during the coming years to bring together data scientists, engineers, researchers, and designers, who will work in collaboration with organizations across Europe to create a new class of cloud-based connected solutions at the intersection of cognitive computing, life sciences, and healthcare. The Center will provide access to resources and technology that can accelerate research into new treatment options, promote personalized medicine, and encourage discoveries aimed at improving overall public health management, while advancing sustainable health systems.

“Italy is important to IBM, not only because of the creativity, skills and talent of the country's workforce, but also because of the Government's efforts to digitize Italy's economy,” said Erich Clementi, senior vice president of IBM Europe. “That is why we are excited to announce our new Watson Health European Center of Excellence near Milan, which will support the Italian Government's healthcare reform and research agenda by bringing together Watson developers and IBM Research scientists to apply remarkable cognitive computing capabilities to modern healthcare problems.”

“Healthcare is undergoing tremendous change, driven by data. The volume and variation of health data is growing exponentially with each passing day and our ability to monitor new measurements of health, such as social data and weather data, are making global health an even more complex equation to solve,” said Deborah DiSanzo, general manager for IBM Watson Health. “This new era in health will not be achieved through solitary efforts. It will require the work of countless experts together in an ecosystem where ideas are easily shared to improve and save lives around the world.”

The Watson Health European Center of Excellence builds on recent IBM investments in Italy and across Europe, including a new IBM Cloud data center in Milan (Italy), and the opening of the Watson Internet of Things (IoT) Global Headquarters in Munich (Germany).

Related Links:
IBM

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Pressure Guidewire
SavvyWire
New
MRI System
nanoScan MRI 3T/7T

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more